AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results
Life Sciences Jobs ... Source: BioSpace
FDA Clarifies the Relief GDUFA II Gives to Small Businesses
Small businesses sponsoring approved generics can expect a 90 percent discount on annual user fees, offering them some relief when GDUFA II takes effect in fiscal 2018. Source: Drug Industry…
Grassley Presses CMS for Records, Answers on Mylan
Sen. Charles Grassley (R-Iowa) put pressure on the Centers for Medicare and Medicaid Service to release records on Mylan’s classification of the epinephrine auto-injector the EpiPen for Medicaid. Source: Drug…
Pharma Companies, Healthcare Groups Urge Trump to Support Value-Based Care
Dozens of healthcare organizations, including several drugmakers and payers, wrote an open letter to President Donald Trump, urging him and Congress to continue the pursuit of value-based care. Source: Drug…
Drugmakers, PhRMA, BIO Push Back Against FDA Proposal for Nonclinical GLPs
Several large drugmakers and industry groups commented on FDA’s proposal to require higher quality management standards for nonclinical studies used to support product applications. Source: Drug Industry Daily
It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-actelion-jean-paul-clozel.jpg" NAME"It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash" ALT"It's Finally Happening: Johnson & Johnson Pays $30…
Biogen Release: Company Reports 2016 Revenues Of $11.4 Billion
Life Sciences Jobs ... Source: BioSpace
Celgene Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-celgene.jpg" NAME"Celgene Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia" ALT"Celgene Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia"January 26, 2017By Mark Terry,…
This Drug Could be Johnson & Johnson's Next Billion-Dollar Blockbuster
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"This Drug Could be Johnson & Johnson's Next Billion-Dollar Blockbuster" ALT"This Drug Could be Johnson & Johnson's Next Billion-Dollar Blockbuster"January 26, 2017By Mark Terry, BioSpace.com Breaking... Source: BioSpace
- Go to the previous page
- 1
- …
- 571
- 572
- 573
- 574
- 575
- 576
- 577
- …
- 610
- Go to the next page